Eyevensys Appoints Dr Ivan Cohen-Tanugi as CEO

News   Mar 26, 2013

 
Eyevensys Appoints Dr Ivan Cohen-Tanugi as CEO
 
 
 

RELATED ARTICLES

Scientists Report The Development of a Potent New Medicine to Fight Addiction

News

Scientists report the development of a potent new medicine to fight addiction.

READ MORE

Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain Therapeutics

News

The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.

READ MORE

Ancient DNA Study Exposes Prehistoric Wanderlust

News

Extensive details about the migration and lives of prehistoric Europeans have been revealed by a huge new genomic study.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE